Education
About Us
Working with TipRanks
Follow Us
Blueprint Medicines (BPMC)
NASDAQ:BPMC
Blueprint Medicines (BPMC) Ownership Overview
1.22% Insiders
42.59% Mutual Funds
32.31% Other Institutional Investors
17.23% ETFs
6.66% Public Companies and Individual Investors
The ownership structure of Blueprint Medicines (BPMC) stock is a mix of institutional, retail, and individual investors. Approximately 92.12% of the company’s stock is owned by Institutional Investors, 1.22% is owned by Insiders, and 6.66% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jun 05, 2025 | xxxxxxxxxxxxx | $340033 | |
Mar 17, 2025 | xxxxxxxxxxxxx | $512021 | |
Mar 07, 2025 | xxxxxxxxxxxxx | $313464 | |
Mar 07, 2025 | xxxxxxxxxxxxx | $576756 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $552036 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $1342077 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $1593268 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $21502442 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,124,432 | Institution | 9.47% | 785,458,404 | |
| 5,479,910 | Institution | 8.47% | 702,798,458 | |
| 2,818,026 | Institution | 4.36% | 361,411,835 | |
| 1,997,279 | Institution | 3.09% | 256,151,032 | |
| 1,816,336 | Institution | 2.81% | 232,945,092 | |
| 1,543,176 | Institution | 2.39% | 197,912,322 | |
| 1,539,139 | Institution | 2.38% | 197,394,577 | |
| 1,204,737 | Institution | 1.86% | 154,507,520 | |
| 913,426 | Institution | 1.41% | 117,146,885 | |
| 859,462 | Institution | 1.33% | 110,226,002 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,479,910 | Institution | 8.47% | 702,798,458 | |
| 1,997,279 | Institution | 3.09% | 256,151,032 | |
| 1,816,336 | Institution | 2.81% | 232,945,092 | |
| 1,543,176 | Institution | 2.39% | 197,912,322 | |
| 1,539,139 | Institution | 2.38% | 197,394,577 | |
| 913,426 | Institution | 1.41% | 117,146,885 | |
| 859,462 | Institution | 1.33% | 110,226,002 | |
| 840,185 | Institution | 1.30% | 107,753,726 | |
| 703,609 | Institution | 1.09% | 90,237,854 | |
| 676,829 | Institution | 1.05% | 86,803,319 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,047,501 | Institution | 3.17% | 207,514,226 | |
| 1,612,016 | Institution | 2.49% | 163,377,822 | |
| 1,580,538 | Institution | 2.44% | 202,703,999 | |
| 1,067,029 | Institution | 1.65% | 136,537,031 | |
| 995,778 | Institution | 1.54% | 100,922,100 | |
| 888,095 | Institution | 1.37% | 90,008,428 | |
| 546,477 | Institution | 0.85% | 70,085,675 | |
| 384,669 | Institution | 0.59% | 49,333,799 | |
| 321,363 | Institution | 0.50% | 32,570,140 | |
| 303,504 | Institution | 0.47% | 38,924,388 |
FAQ
Who Owns Blueprint Medicines (BPMC)?
According to the latest TipRanks data, approximately 32.31% of the company's stock is held by institutional investors, 1.22% is held by insiders, and 6.66% is held by retail investors.
What percentage of Blueprint Medicines (BPMC) stock is held by institutional investors?
According to the latest TipRanks data, approximately 32.31% of Blueprint Medicines (BPMC) stock is held by institutional investors.
What percentage of Blueprint Medicines (BPMC) stock is held by retail investors?
According to the latest TipRanks data, approximately 6.66% of Blueprint Medicines (BPMC) stock is held by retail investors.
Who owns the most shares of Blueprint Medicines (BPMC)?
Vanguard owns the most shares of Blueprint Medicines (BPMC).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.